Abstract
P15-10. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
Highlights
Thailand, site of numerous HIV chemoprophylaxis trials and the world's only ongoing phase-3 HIV vaccine trial, may be an early adopter of HIV vaccines
AIDS Vaccine 2009 Anna Laura Ross Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf
We assessed acceptability of preventive HIV vaccines and behavioral risk compensation among individuals from high-risk communities likely to be targeted for initial vaccine rollout
Summary
Address: 1University of Toronto, Toronto, Canada, 2King Mongkut University of Technology, North Bangkok, Thailand and 3Chiang Mai University, Chiang Mai, Thailand. Published: 22 October 2009 Retrovirology 2009, 6(Suppl 3):P211 doi:10.1186/1742-4690-6-S3-P211. AIDS Vaccine 2009 Anna Laura Ross Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
